An intensive study shows that Prdx6−/− develop insulin resistance, diabetic dyslipidemia, impaired insulin signaling, morphological changes in the pancreas and liver, and increased pro-inflammatory responses, suggesting that Prdx6 deficiency is a key mediator of hyperglycemia in type 2 diabetes [118]. Here, PRDX6 is linked to type 2 diabetes mellitus.